DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$56.1B
1-Year Return
19.33%
This Quarter Return
+6.89%
1 Year Return
+19.33%
3 Year Return
+93.16%
5 Year Return
+155.59%
10 Year Return
+349.91%
AUM
$53.9B
AUM Growth
-$1.63B
(-2.9%)
Cap. Flow
-$3.64B
Cap. Flow
% of AUM
-6.75%
Top 10 Holdings %
Top 10 Hldgs %
26.17%
Holding
1,489
New
41
Increased
394
Reduced
550
Closed
60
Top Buys
| 1 |
CVS Health
CVS
|
+$78.6M |
| 2 |
Sysco
SYY
|
+$55.4M |
| 3 |
Progressive
PGR
|
+$44.2M |
| 4 |
Exxon Mobil
XOM
|
+$42.4M |
| 5 |
Mondelez International
MDLZ
|
+$27.4M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$1.67B |
| 2 |
Broadcom
AVGO
|
+$1.19B |
| 3 |
Amazon
AMZN
|
+$116M |
| 4 |
Canadian Natural Resources
CNQ
|
+$74.1M |
| 5 |
Gilead Sciences
GILD
|
+$66M |
Sector Composition
| 1 | Technology | 27.08% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 10.83% |
| 4 | Industrials | 10.14% |
| 5 | Consumer Discretionary | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
COPT Defense Properties
CDP
$3.45B
| $812K | ﹤0.01% |
26,964
| – | – |
|
927
Kymera Therapeutics
KYMR
$3.11B
| $801K | ﹤0.01% |
23,562
| – | – |
|
928
Regenxbio
RGNX
$483M
| $795K | ﹤0.01% |
74,600
| – | – |
|
929
HUTCHMED
HCM
$2.7B
| $785K | ﹤0.01% |
41,362
| – | – |
|
930
ImmunityBio
IBRX
$2.43B
| $782K | ﹤0.01% |
196,200
| – | – |
|
931
Apple Hospitality REIT
APLE
$2.97B
| $765K | ﹤0.01% |
51,325
| – | – |
|
|
AAT
932
American Assets Trust
AAT
$1.25B
| $763K | ﹤0.01% |
35,179
+9,620
| +38% | +$209K |
|
933
Insight Enterprises
NSIT
$3.96B
| $744K | ﹤0.01% |
3,529
| – | – |
|
934
VF Corp
VFC
$5.85B
| $741K | ﹤0.01% |
38,110
| – | – |
|
935
BW LPG
BWLP
$2.38B
| $740K | ﹤0.01% |
50,012
+12,622
| +34% | +$187K |
|
936
Fortrea Holdings
FTRE
$909M
| $738K | ﹤0.01% |
38,219
| – | – |
|
937
Arrowhead Research
ARWR
$3.99B
| $737K | ﹤0.01% |
37,844
+1,609
| +4% | +$31.3K |
|
938
Crane Co
CR
$10.5B
| $730K | ﹤0.01% |
4,709
| – | – |
|
939
Kontoor Brands
KTB
$4.29B
| $725K | ﹤0.01% |
8,904
| – | – |
|
940
Tanger
SKT
$3.86B
| $724K | ﹤0.01% |
25,340
| – | – |
|
941
Wolfspeed
WOLF
$230M
| $722K | ﹤0.01% |
72,690
-20,209
| -22% | -$201K |
|
942
Jones Lang LaSalle
JLL
$14.6B
| $720K | ﹤0.01% |
2,712
-982
| -27% | -$261K |
|
943
Mr. Cooper
COOP
$14B
| $715K | ﹤0.01% |
7,931
| – | – |
|
944
Protagonist Therapeutics
PTGX
$3.59B
| $709K | ﹤0.01% |
15,800
| – | – |
|
945
FirstCash
FCFS
$6.46B
| $703K | ﹤0.01% |
6,200
| – | – |
|
|
GAP
946
The Gap, Inc.
GAP
$8.93B
| $698K | ﹤0.01% |
32,756
-4,846
| -13% | -$103K |
|
947
e.l.f. Beauty
ELF
$7.63B
| $697K | ﹤0.01% |
6,290
+2,826
| +82% | +$313K |
|
948
LXP Industrial Trust
LXP
$2.67B
| $692K | ﹤0.01% |
69,306
| – | – |
|
949
Unity
U
$18.2B
| $691K | ﹤0.01% |
30,568
+3,727
| +14% | +$84.3K |
|
950
Supernus Pharmaceuticals
SUPN
$2.59B
| $674K | ﹤0.01% |
22,200
| – | – |
|